Published in Clin Vaccine Immunol on December 18, 2013
Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine. Immunol Cell Biol (2017) 1.09
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag (2014) 0.92
Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma. J Cancer Res Clin Oncol (2015) 0.80
EBV-Associated Cancer and Autoimmunity: Searching for Therapies. Vaccines (Basel) (2015) 0.75
Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo. BMC Cancer (2017) 0.75
Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma. PLoS One (2015) 0.75
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med (2009) 5.79
Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol (2007) 4.14
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet (1995) 4.07
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes. Blood (2004) 4.01
Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases. Annu Rev Microbiol (2000) 2.17
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J Clin Oncol (2005) 2.10
Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proc Natl Acad Sci U S A (1999) 1.82
Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res (1999) 1.82
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J Immunol (1997) 1.78
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity. Clin Cancer Res (2008) 1.66
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma. J Immunother (2010) 1.50
Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res (2012) 1.33
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol (2000) 1.06
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation (2003) 1.05
Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res (2001) 1.02
Epstein-Barr virus in tumours. Histopathology (1996) 0.97
Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients. Immunol Cell Biol (2009) 0.85
Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev (2007) 6.00
A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (2003) 4.49
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques. Bioinformatics (2009) 3.00
Opportunities and challenges for smartphone applications in supporting health behavior change: qualitative study. J Med Internet Res (2013) 2.70
Cost-effective three-dimensional printing of visibly transparent microchips within minutes. Anal Chem (2014) 1.71
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice. J Virol (2006) 1.66
Head and neck cancer: past, present and future. Expert Rev Anticancer Ther (2006) 1.63
A review of standards for data exchange within systems biology. Proteomics (2007) 1.61
Nucleotide polymorphism and phenotypic associations within and around the phytochrome B2 Locus in European aspen (Populus tremula, Salicaceae). Genetics (2008) 1.61
Hard wiring of T cell receptor specificity for the major histocompatibility complex is underpinned by TCR adaptability. Proc Natl Acad Sci U S A (2010) 1.60
The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res (2015) 1.49
Novel markers for poor prognosis in head and neck cancer. Int J Cancer (2005) 1.48
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med (2004) 1.45
Early onset severe pre-eclampsia: expectant management at a secondary hospital in close association with a tertiary institution. BJOG (2005) 1.39
Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy. Cancer Res (2012) 1.33
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis. J Virol (2007) 1.28
Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res (2012) 1.26
Toxicogenomics of nevirapine-associated cutaneous and hepatic adverse events among populations of African, Asian, and European descent. AIDS (2011) 1.23
Automated reconstruction of ancient languages using probabilistic models of sound change. Proc Natl Acad Sci U S A (2013) 1.23
Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope (2005) 1.21
Clinal variation in phyB2, a candidate gene for day-length-induced growth cessation and bud set, across a latitudinal gradient in European aspen (Populus tremula). Genetics (2005) 1.19
Leaving paediatrics: the experience of service transition for young disabled people and their family carers. Health Soc Care Community (1998) 1.18
Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients. J Immunol (2010) 1.14
Molecular evolution and emergence of avian gammacoronaviruses. Infect Genet Evol (2012) 1.13
Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype. J Immunol (2003) 1.08
Further studies on sex pheromones of female Lygus and related bugs: development of effective lures and investigation of species-specificity. J Chem Ecol (2014) 1.07
Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation (2003) 1.05
Parotidectomy: review of treatment and outcomes. ANZ J Surg (2004) 1.05
Assessment of applicants to the veterinary curriculum using a multiple mini-interview method. J Vet Med Educ (2009) 1.04
Gene flow and selection on phenotypic plasticity in an island system of Rana temporaria. Evolution (2010) 1.04
miRNAs in head and neck cancer revisited. Cell Oncol (Dordr) (2013) 1.03
Primary care for children in the 21st century. BMJ (2005) 1.02
Genetic differentiation, clinal variation and phenotypic associations with growth cessation across the Populus tremula photoperiodic pathway. Genetics (2010) 1.00
Heat treatment eliminates 'Candidatus Liberibacter asiaticus' from infected citrus trees under controlled conditions. Phytopathology (2013) 0.98
Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg (2004) 0.97
Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. J Infect Dis (2008) 0.96
Tumor-suppressor Gene Promoter Hypermethylation in Saliva of Head and Neck Cancer Patients. Transl Oncol (2012) 0.96
Specific exercises to treat pregnancy-related low back pain in a South African population. Int J Gynaecol Obstet (2011) 0.94
Does brief telephone support improve engagement with a web-based weight management intervention? Randomized controlled trial. J Med Internet Res (2014) 0.94
Children's health and development: approaches to early identification and intervention. Arch Dis Child (2013) 0.93
T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years. Blood (2005) 0.93
Total pharyngolaryngectomy for squamous cell carcinoma of the hypopharynx: a review. Laryngoscope (2005) 0.93
Child protection--lessons from Victoria Climbié. BMJ (2003) 0.92
Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases. Neuroscientist (2008) 0.92
Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma. Am J Hematol (2011) 0.92
Time between skin incision and delivery during cesarean. Int J Gynaecol Obstet (2013) 0.91
Phenotypes and karyotypes of human malignant mesothelioma cell lines. PLoS One (2013) 0.90
A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol (Dordr) (2014) 0.90
Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. Int Immunol (2004) 0.88
Safeguarding children: a call to action. Lancet (2008) 0.88
Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients. Immunol Cell Biol (2009) 0.87
Integration of absorption, distribution, metabolism, and elimination genotyping data into a population pharmacokinetic analysis of nevirapine. Pharmacogenet Genomics (2011) 0.86
Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia. J Virol (2004) 0.86
What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg (2004) 0.86
A first-generation multi-functional cytokine for simultaneous optical tracking and tumor therapy. PLoS One (2012) 0.86
Anatomical and computed tomographic analysis of the transcochlear and endoscopic transclival approaches to the petroclival region. Laryngoscope (2013) 0.86
Qualification discrepancies between urban and rural emergency department physicians. J Emerg Med (2005) 0.86
Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patients. Immunol Cell Biol (2009) 0.85
T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production. Int Immunol (2006) 0.85
Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples. J Virol Methods (2012) 0.85
Mortality after discharge from long-term psychiatric care in Scotland, 1977-94: a retrospective cohort study. BMC Public Health (2003) 0.85
Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders. Blood (2010) 0.85
Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. S Afr Med J (2011) 0.85
Traumatic retropharyngeal haematoma in an anticoagulated patient: Case report and proposal for a clinical protocol. Acta Otolaryngol (2005) 0.84
Lingual thyroid: an unusual and surgically curable cause of sleep apnoea in a male. Sleep Breath (2010) 0.84
Enhancing magnetic resonance imaging tumor detection with fluorescence intensity and lifetime imaging. J Biomed Opt (2011) 0.84
Great auricular nerve perineural spread of squamous cell carcinoma. ANZ J Surg (2012) 0.84
Total perinatally related losses at Tygerberg Hospital - a comparison between 1986, 1993 and 2006. S Afr Med J (2010) 0.84
Invasion and metastasis markers in cancers. Br J Plast Surg (2005) 0.84
Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical metastasis. ANZ J Surg (2007) 0.84
A Visualization Tool to Analyse Usage of Web-Based Interventions: The Example of Positive Online Weight Reduction (POWeR). JMIR Hum Factors (2015) 0.83
Access to the parapharyngeal space: an anatomical study comparing the endoscopic and open approaches. Laryngoscope (2013) 0.83
Novel approach to the formulation of an Epstein-Barr virus antigen-based nasopharyngeal carcinoma vaccine. J Virol (2010) 0.83
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2239633, a CC-chemokine receptor 4 antagonist, in healthy male subjects: results from an open-label and from a randomised study. BMC Pharmacol Toxicol (2013) 0.83
Balance, mobility and gaze stability deficits remain following surgical removal of vestibular schwannoma (acoustic neuroma): an observational study. Aust J Physiother (2006) 0.83
Contrasting signal transduction mechanisms in bacterial and eukaryotic gene transcription. FEMS Microbiol Lett (2006) 0.83
Vestibular schwannoma: an understanding of growth should influence management decisions. Otol Neurotol (2008) 0.83
Reduced alphaB-crystallin staining in perineural invasion of head and neck cutaneous squamous cell carcinoma. Otolaryngol Head Neck Surg (2010) 0.83
Basic consideration of research strategies for head and neck cancer. Front Med (2012) 0.83
Valproic acid as a therapeutic agent for head and neck squamous cell carcinomas. Cancer Chemother Pharmacol (2008) 0.83
Sphenoid sinus fungal balls. Ann Otol Rhinol Laryngol (2007) 0.83
Epidemiology of clinical perineural invasion in cutaneous squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg (2012) 0.83
An initial evaluation of post-cardiopulmonary bypass acute kidney injury in swine. Eur J Cardiothorac Surg (2009) 0.82
Clonal population structure of the chestnut blight fungus in expanding ranges in southeastern Europe. Mol Ecol (2008) 0.82
Cutaneous head and neck malignancies with perineural spread to contralateral cranial nerves: an argument for extending postoperative radiotherapy volume. J Clin Oncol (2013) 0.82
Long-term functional speech and swallowing outcomes following pharyngolaryngectomy with free jejunal flap reconstruction. Ann Plast Surg (2010) 0.81
The anti-cancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cells. Haematologica (2009) 0.81